Canada
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
68.17 |
Jan. 14, 2025 | USD 1.93 | -6.31% |
|
Canada |
|
2 |
51.59 |
Jan. 14, 2025 | USD 0.11 | 0.09% |
|
Canada |
|
3 |
30.28 |
Jan. 14, 2025 | USD 7.26 | -2.32% |
|
Canada |
|
4 |
13.32 |
Jan. 14, 2025 | USD 2.88 | 1.69% |
|
Canada |
|
5 |
11.37 |
Jan. 14, 2025 | USD 9.40 | -4.39% |
|
Canada |
|
6 |
5.15 |
Jan. 14, 2025 | USD 10.44 | 1.50% |
|
Canada |
|
7 |
1.98 |
Jan. 14, 2025 | USD 4.65 | 1.12% |
|
Canada |
|
8 |
1.96 |
Jan. 14, 2025 | USD 23.94 | 0.98% |
|
Canada |
|
9 |
1.64 |
Jan. 14, 2025 | USD 1.53 | -2.45% |
|
Canada |
|
10 |
1.52 |
Jan. 14, 2025 | USD 13.41 | 0.42% |
|
Canada |
|
11 |
1.51 |
Jan. 14, 2025 | USD 2.23 | -6.78% |
|
Canada |
|
12 |
1.50 |
Jan. 14, 2025 | USD 3.69 | 0.40% |
|
Canada |
|
13 |
1.42 |
Jan. 14, 2025 | USD 10.21 | -0.73% |
|
Canada |
|
14 |
1.40 |
Jan. 14, 2025 | USD 1.18 | -0.37% |
|
Canada |
|
15 |
1.36 |
Jan. 14, 2025 | USD 2.70 | 2.33% |
|
Canada |
|
16 |
1.08 |
Jan. 14, 2025 | USD 3.94 | -2.21% |
|
Canada |
|
17 |
1.00 |
Jan. 14, 2025 | USD 5.48 | -0.17% |
|
Canada |
|
18 |
0.96 |
Jan. 14, 2025 | USD 1.71 | 4.46% |
|
Canada |
|
19 |
0.88 |
Jan. 14, 2025 | USD 62.02 | -1.08% |
|
Canada |
|
20 |
0.83 |
Jan. 14, 2025 | USD 122.81 | -2.58% |
|
Canada |
|
21 |
0.68 |
Jan. 14, 2025 | USD 3.11 | 5.40% |
|
Canada |
|
22 |
0.61 |
Jan. 14, 2025 | USD 7.18 | 2.10% |
|
Canada |
|
23 |
0.60 |
Jan. 14, 2025 | USD 4.08 | -3.32% |
|
Canada |
|
24 |
0.57 |
Jan. 14, 2025 | USD 10.89 | 1.12% |
|
Canada |
|
25 |
0.34 |
Jan. 14, 2025 | USD 1.51 | -0.70% |
|
Canada |
|
26 |
0.31 |
Jan. 14, 2025 | USD 7.49 | 1.16% |
|
Canada |
The Health Care company in Canada with the highest Price to Sales Ratio (P/S) is Lexaria Bioscience Corp. (NasdaqCM: LEXX) at 68.17.
The Health Care company in Canada with the lowest Price to Sales Ratio (P/S) is Bausch Health Companies Inc. (Toronto Stock Exchange: BHC.TO) at 0.31.
The top 10 Health Care companies in Canada by Price to Sales Ratio (P/S) are Lexaria Bioscience Corp., Ondine Biomedical Inc., Profound Medical Corp., EcoSynthetix Inc., Cipher Pharmaceuticals Inc., Chartwell Retirement Residences, WELL Health Technologies Corp., Jamieson Wellness Inc., OrganiGram Holdings Inc. and Savaria Corporation.
The bottom 10 Health Care companies in Canada by Price to Sales Ratio (P/S) are Bausch Health Companies Inc., CareRx Corporation, Medical Facilities Corporation, InMed Pharmaceuticals Inc., Extendicare Inc., Medexus Pharmaceuticals Inc., Loblaw Companies Limited, Metro Inc., Theratechnologies Inc. and dentalcorp Holdings Ltd..